Topics and Sessions
Main Topics
- Cardiometabolic Risk Management & Prediction
- Lipids
- Lipoproteins Disorders
- Inflammation & Thrombosis
- Diabetes
- Obesity
- Hypertension
- Metabolic Syndrome
- Chronic Kidney Disease
- Metabolic Liver Disease
- Environmental Health & Pollution
- Health Economics
- Health Ethics & Equity
- Personalised Medicine, Genomics, and Omics
- Digital Health Technologies & Artificial Intelligence
- Imaging
- Patient and Citizens Involvement
- Social Media: Role & Use
Topics of Parallel Sessions
- Advances in familial hypercholesterolemia
- Applying artificial intelligence and omics technologies in atherosclerotic cardiovascular disease
- Challenges and opportunities in cardiometabolic diseases in a social context: Role of social media, ethics, patient communities and educational programs
- Diabetes and atherosclerosis: Prevention, management, and personalized care
- Dyslipidemia and cardiovascular disease in pediatric age group
- Dyslipidemia in microvascular complications in diabetic patients
- Emerging new therapies and gene therapies in atherosclerotic cardiovascular diseases
- Emerging role of environment and pollution in cardiovascular disease
- Emerging science in cardiovascular disease and role of inflammation, stress, and thrombosis
- Health economics and policy considerations related to cardiometabolic diseases
- Latest clinical trial design, in-process, outcome
- Lipoprotein(a), HDL and apoB in atherosclerosis: Pathophysiology, diagnosis, and treatment
- Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): Epidemiology, pathogenesis, and treatment
- Novel biomarkers and new emerging technology in atherosclerotic disease
- Novel therapies for obesity and cardiometabolic diseases
- Obesity and cardiometabolic diseases: Role of adipose tissue, inflammation, and gut microbiota
- Precision medicine in atherosclerotic disease: Challenges and opportunities
- Recent advances in imaging in atherosclerotic cardiovascular disease
- Registries on lipid disorders and screening programs
- Renocardiac syndrome: Pathophysiology, diagnosis, prevention, and treatment
- Role of lifestyle intervention, behavior, and nutraceuticals in management of chronic comorbidities related to heart disease
- Triglyceride-rich lipoproteins and cardiovascular disease: Implications for prevention and treatment
- Women’s cardiovascular health issues
© Copyright 2005 - 2024 MCI Global. All Rights Reserved.